Please Wait
Applying Filters...
menu
    • menu
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Cangrelor Tetrasodium

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 491,050Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Gland Pharma Gets FDA Nod for Cangrelor Injection 50 mg/vial
    Gland Pharma Gets FDA Nod for Cangrelor Injection 50 mg/vial

    12 Aug 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/drug-approval/gland-pharma-receives-fda-approval-for-cangrelor-for-injection-50-mgvial-17593

    INDPHARMAPOST
    12 Aug 2025
    Share Share
    Gland’s Receives First Generic Approval for Cangrelor in US
    Gland’s Receives First Generic Approval for Cangrelor in US

    11 Aug 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=213551

    FDA
    11 Aug 2025
    Share Share
    Gland`s Generics Cangrelor Receives Approval in US
    Gland`s Generics Cangrelor Receives Approval in US

    11 Aug 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213551

    FDA
    11 Aug 2025
    Share Share
    Chiesi USA Announces 1st Analysis from the CAMEO Registry Assessing KENGREAL Use
    Chiesi USA Announces 1st Analysis from the CAMEO Registry Assessing KENGREAL Use

    01 Jun 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/06/01/2454378/0/en/Chiesi-USA-Announces-First-Analysis-from-the-CAMEO-Registry-Assessing-KENGREAL-cangrelor-Use-and-Transition-to-Oral-P2Y12-Inhibitors-in-Routine-Clinical-Practice.html

    GLOBENEWSWIRE
    01 Jun 2022
    Share Share
    Chiesi USA Publishes Post Hoc Analysis on Ischemic Events & KENGREAL's role
    Chiesi USA Publishes Post Hoc Analysis on Ischemic Events & KENGREAL's role

    25 Jan 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/01/25/2372632/0/en/Chiesi-USA-Announces-New-Publication-of-Post-Hoc-Analysis-on-Timing-of-Ischemic-Events-in-Cardiac-Patients-and-Role-of-KENGREAL-cangrelor-in-Reducing-Risk.html

    GLOBENEWSWIRE
    25 Jan 2022
    Share Share
    Apotex's Generic Metformin HCl Receives Approval in the U.S.
    Apotex's Generic Metformin HCl Receives Approval in the U.S.

    13 Dec 2021

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213356

    FDA
    13 Dec 2021
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.